Michael Garron Hospital, formerly Toronto East General Hospital, is a community teaching hospital located at 825 Coxwell Avenue in East York, Toronto, Ontario, Canada.

There are 515 beds in Toronto East General Hospital.

During the past decade, Toronto East General Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 19 clinical trials were completed, i.e. on average, 118.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toronto East General Hospital" #1 sponsor was "NCIC Clinical Trials Group" with 13 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "The Hospital for Sick Children" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "Canadian Cancer Trials Group" with 3 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toronto East General Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 7 trials as a collaborator, "National Cancer Institute (NCI)" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 88 different institutions and companies that were collaborators in the rest 79 trials.

According to Clinical.Site data, the most researched conditions in "Toronto East General Hospital" are "Breast Cancer" (9 trials), "Colorectal Cancer" (5 trials), "Influenza" (3 trials), "Lung Cancer" (3 trials) and "Bladder Cancer" (2 trials). Many other conditions were trialed in "Toronto East General Hospital" in a lesser frequency.

Most popular intervention types in "Toronto East General Hospital" are "Drug" (47 trials), "Other" (16 trials), "Biological" (6 trials), "Procedure" (6 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "placebo" (5 trials), "cetuximab" (4 trials), "Laboratory Biomarker Analysis" (3 trials) and "Quality-of-Life Assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "Toronto East General Hospital" are 51 trials for "All" genders and 16 trials for "Female" genders.

Currently, there are NaN active trials in "Toronto East General Hospital". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Toronto East General Hospital, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Toronto East General Hospital, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 11 trials that are defined as “Not Applicable".

Toronto East General Hospital has several departments that took part in Clinical trials: "Toronto East General Hospital; Haematology/Oncology" - 4 trials